BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Huang Y, Dai Y, Yang J, Chen T, Yin Y, Tang M, Hu C, Zhang L. Microarray analysis of microRNA expression in renal clear cell carcinoma. European Journal of Surgical Oncology (EJSO) 2009;35:1119-23. [DOI: 10.1016/j.ejso.2009.04.010] [Cited by in Crossref: 56] [Cited by in F6Publishing: 54] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Chen Y, Liu W, Li D, Cao Y, Wang W, Li C, An R. MiRNA-148a inhibits cell growth and drug resistance by regulating WNT10a expression in renal cell carcinoma. Transl Androl Urol 2022;11:996-1006. [PMID: 35958896 DOI: 10.21037/tau-22-464] [Reference Citation Analysis]
2 Miranda-Poma J, Trilla-Fuertes L, López-Camacho E, Zapater-Moros A, López-Vacas R, Lumbreras-Herrera MI, Pertejo-Fernandez A, Fresno-Vara JÁ, Espinosa-Arranz E, Gámez-Pozo A, Pinto-Marín Á. MiRNAs in renal cell carcinoma. Clin Transl Oncol 2022. [PMID: 35729452 DOI: 10.1007/s12094-022-02866-z] [Reference Citation Analysis]
3 Li F, Feng Y, Jiang Q, Zhang J, Wu F, Li Q, Jing X, Wang X, Huang C. Pan-cancer analysis, cell and animal experiments revealing TEAD4 as a tumor promoter in ccRCC. Life Sciences 2022;293:120327. [DOI: 10.1016/j.lfs.2022.120327] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Chen P, Jiang L, Xie X, Sun D, Liu J, Zhao Y, Li Y, Balbín Tamayo AI, Liu B, Miao Y, Ouyang R. Rapid electrochemical detection of MiRNA-21 facilitated by the excellent catalytic ability of Pt@CeO 2 nanospheres. RSC Adv 2022;12:11867-76. [DOI: 10.1039/d2ra01047j] [Reference Citation Analysis]
5 Paul P, Malakar AK, Chakraborty S. The significance of gene mutations across eight major cancer types. Mutat Res Rev Mutat Res 2019;781:88-99. [PMID: 31416581 DOI: 10.1016/j.mrrev.2019.04.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
6 Tsiakanikas P, Giaginis C, Kontos CK, Scorilas A. Clinical utility of microRNAs in renal cell carcinoma: current evidence and future perspectives. Expert Review of Molecular Diagnostics 2018;18:981-91. [DOI: 10.1080/14737159.2018.1539668] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
7 Crentsil VC, Liu H, Sellitti DF. Comparison of exosomal microRNAs secreted by 786-O clear cell renal carcinoma cells and HK-2 proximal tubule-derived cells in culture identifies microRNA-205 as a potential biomarker of clear cell renal carcinoma. Oncol Lett 2018;16:1285-90. [PMID: 30061948 DOI: 10.3892/ol.2018.8751] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
8 Wang J, Wang S, Luan Y, Zhang W, Sun C, Cheng G, Li K, Xin Q, Lin Z, Qi T, Kong F. Overexpression of NEDD9 in renal cell carcinoma is associated with tumor migration and invasion. Oncol Lett 2017;14:8021-7. [PMID: 29344245 DOI: 10.3892/ol.2017.7231] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
9 Lawrie CH, Armesto M, Fernandez-Mercado M, Arestín M, Manterola L, Goicoechea I, Larrea E, Caffarel MM, Araujo AM, Sole C, Sperga M, Alvarado-Cabrero I, Michal M, Hes O, López JI. Noncoding RNA Expression and Targeted Next-Generation Sequencing Distinguish Tubulocystic Renal Cell Carcinoma (TC-RCC) from Other Renal Neoplasms. J Mol Diagn 2018;20:34-45. [PMID: 29056573 DOI: 10.1016/j.jmoldx.2017.09.002] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
10 Li G, Zhao A, Péoch M, Cottier M, Mottet N. Detection of urinary cell-free miR-210 as a potential tool of liquid biopsy for clear cell renal cell carcinoma. Urologic Oncology: Seminars and Original Investigations 2017;35:294-9. [DOI: 10.1016/j.urolonc.2016.12.007] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 5.0] [Reference Citation Analysis]
11 Morris MR, Latif F. The epigenetic landscape of renal cancer. Nat Rev Nephrol 2017;13:47-60. [PMID: 27890923 DOI: 10.1038/nrneph.2016.168] [Cited by in Crossref: 57] [Cited by in F6Publishing: 64] [Article Influence: 9.5] [Reference Citation Analysis]
12 Del Pino Curbelo M, Rodríguez Rodríguez A, Buxeda i Garrigós J, Mangas Viñuela J, Day PM, González Quintero P, Moreno Benítez MA. Las cerámicas aborígenes de Gran Canaria (Islas Canarias) a través del yacimiento de La Cerera: materias primas, tecnología y función. Trab prehist 2016;73:90-114. [DOI: 10.3989/tp.2016.12165] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
13 Li Y, Li J, Sun X, Chen J, Sun X, Zheng J, Chen R. MicroRNA-27a functions as a tumor suppressor in renal cell carcinoma by targeting epidermal growth factor receptor. Oncol Lett 2016;11:4217-23. [PMID: 27313769 DOI: 10.3892/ol.2016.4500] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
14 Xiang W, He J, Huang C, Chen L, Tao D, Wu X, Wang M, Luo G, Xiao X, Zeng F, Jiang G. miR-106b-5p targets tumor suppressor gene SETD2 to inactive its function in clear cell renal cell carcinoma. Oncotarget 2015;6:4066-79. [PMID: 25714014 DOI: 10.18632/oncotarget.2926] [Cited by in Crossref: 44] [Cited by in F6Publishing: 44] [Article Influence: 7.3] [Reference Citation Analysis]
15 Shi Q, Xu X, Liu Q, Luo F, Shi J, He X. MicroRNA-877 acts as a tumor suppressor by directly targeting eEF2K in renal cell carcinoma. Oncol Lett 2016;11:1474-80. [PMID: 26893763 DOI: 10.3892/ol.2015.4072] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
16 Fritz HK, Gustafsson A, Ljungberg B, Ceder Y, Axelson H, Dahlbäck B. The Axl-Regulating Tumor Suppressor miR-34a Is Increased in ccRCC but Does Not Correlate with Axl mRNA or Axl Protein Levels. PLoS One 2015;10:e0135991. [PMID: 26287733 DOI: 10.1371/journal.pone.0135991] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
17 He H, Wang L, Zhou W, Zhang Z, Wang L, Xu S, Wang D, Dong J, Tang C, Tang H, Yi X, Ge J. MicroRNA Expression Profiling in Clear Cell Renal Cell Carcinoma: Identification and Functional Validation of Key miRNAs. PLoS One 2015;10:e0125672. [PMID: 25938468 DOI: 10.1371/journal.pone.0125672] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 5.0] [Reference Citation Analysis]
18 Papadopoulos EI, Yousef GM, Scorilas A. Gemcitabine impacts differentially on bladder and kidney cancer cells: distinct modulations in the expression patterns of apoptosis-related microRNAs and BCL2 family genes. Tumour Biol 2015;36:3197-207. [PMID: 25833690 DOI: 10.1007/s13277-014-2190-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
19 Teferedegne B, Macauley J, Foseh G, Dragunsky E, Chumakov K, Murata H, Peden K, Lewis AM. MicroRNAs as potential biomarkers for VERO cell tumorigenicity. Vaccine 2014;32:4799-805. [DOI: 10.1016/j.vaccine.2014.05.065] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
20 Bera A, Das F, Ghosh-Choudhury N, Kasinath BS, Abboud HE, Choudhury GG. microRNA-21-induced dissociation of PDCD4 from rictor contributes to Akt-IKKβ-mTORC1 axis to regulate renal cancer cell invasion. Exp Cell Res 2014;328:99-117. [PMID: 25016284 DOI: 10.1016/j.yexcr.2014.06.022] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 3.8] [Reference Citation Analysis]
21 Xu X, Wu J, Li S, Hu Z, Xu X, Zhu Y, Liang Z, Wang X, Lin Y, Mao Y, Chen H, Luo J, Liu B, Zheng X, Xie L. Downregulation of microRNA-182-5p contributes to renal cell carcinoma proliferation via activating the AKT/FOXO3a signaling pathway. Mol Cancer 2014;13:109. [PMID: 24886554 DOI: 10.1186/1476-4598-13-109] [Cited by in Crossref: 71] [Cited by in F6Publishing: 71] [Article Influence: 8.9] [Reference Citation Analysis]
22 Zaravinos A, Lambrou GI, Mourmouras N, Katafygiotis P, Papagregoriou G, Giannikou K, Delakas D, Deltas C. New miRNA profiles accurately distinguish renal cell carcinomas and upper tract urothelial carcinomas from the normal kidney. PLoS One 2014;9:e91646. [PMID: 24621579 DOI: 10.1371/journal.pone.0091646] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 3.9] [Reference Citation Analysis]
23 Wei Q, Mi QS, Dong Z. The regulation and function of microRNAs in kidney diseases. IUBMB Life 2013;65:602-14. [PMID: 23794512 DOI: 10.1002/iub.1174] [Cited by in Crossref: 69] [Cited by in F6Publishing: 66] [Article Influence: 8.6] [Reference Citation Analysis]
24 Lawrie CH, Larrea E, Larrinaga G, Goicoechea I, Arestin M, Fernandez-mercado M, Hes O, Cáceres F, Manterola L, López JI. Targeted next-generation sequencing and non-coding RNA expression analysis of clear cell papillary renal cell carcinoma suggests distinct pathological mechanisms from other renal tumour subtypes: Molecular analysis of clear cell papillary renal cell carcinoma. J Pathol 2014;232:32-42. [DOI: 10.1002/path.4296] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 3.9] [Reference Citation Analysis]
25 Fachel AA, Tahira AC, Vilella-Arias SA, Maracaja-Coutinho V, Gimba ER, Vignal GM, Campos FS, Reis EM, Verjovski-Almeida S. Expression analysis and in silico characterization of intronic long noncoding RNAs in renal cell carcinoma: emerging functional associations. Mol Cancer 2013;12:140. [PMID: 24238219 DOI: 10.1186/1476-4598-12-140] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 4.9] [Reference Citation Analysis]
26 Doberstein K, Steinmeyer N, Hartmetz AK, Eberhardt W, Mittelbronn M, Harter PN, Juengel E, Blaheta R, Pfeilschifter J, Gutwein P. MicroRNA-145 targets the metalloprotease ADAM17 and is suppressed in renal cell carcinoma patients. Neoplasia 2013;15:218-30. [PMID: 23441135 DOI: 10.1593/neo.121222] [Cited by in Crossref: 62] [Cited by in F6Publishing: 57] [Article Influence: 6.9] [Reference Citation Analysis]
27 Bera A, Ghosh-Choudhury N, Dey N, Das F, Kasinath BS, Abboud HE, Choudhury GG. NFκB-mediated cyclin D1 expression by microRNA-21 influences renal cancer cell proliferation. Cell Signal 2013;25:2575-86. [PMID: 23981302 DOI: 10.1016/j.cellsig.2013.08.005] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 3.3] [Reference Citation Analysis]
28 Cheng T, Wang L, Li Y, Huang C, Zeng L, Yang J. Differential microRNA expression in renal cell carcinoma. Oncol Lett 2013;6:769-76. [PMID: 24137408 DOI: 10.3892/ol.2013.1460] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 3.3] [Reference Citation Analysis]
29 Chen J, Zhang D, Zhang W, Tang Y, Yan W, Guo L, Shen B. Clear cell renal cell carcinoma associated microRNA expression signatures identified by an integrated bioinformatics analysis. J Transl Med 2013;11:169. [PMID: 23841900 DOI: 10.1186/1479-5876-11-169] [Cited by in Crossref: 37] [Cited by in F6Publishing: 40] [Article Influence: 4.1] [Reference Citation Analysis]
30 Zhang WB, Pan ZQ, Yang QS, Zheng XM. Tumor suppressive miR-509-5p contributes to cell migration, proliferation and antiapoptosis in renal cell carcinoma. Ir J Med Sci 2013;182:621-7. [PMID: 23619562 DOI: 10.1007/s11845-013-0941-y] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
31 Zhao A, Li G, Péoc'h M, Genin C, Gigante M. Serum miR-210 as a novel biomarker for molecular diagnosis of clear cell renal cell carcinoma. Experimental and Molecular Pathology 2013;94:115-20. [DOI: 10.1016/j.yexmp.2012.10.005] [Cited by in Crossref: 104] [Cited by in F6Publishing: 99] [Article Influence: 11.6] [Reference Citation Analysis]
32 Cui L, Zhou H, Zhao H, Zhou Y, Xu R, Xu X, Zheng L, Xue Z, Xia W, Zhang B, Ding T, Cao Y, Tian Z, Shi Q, He X. MicroRNA-99a induces G1-phase cell cycle arrest and suppresses tumorigenicity in renal cell carcinoma. BMC Cancer 2012;12:546. [PMID: 23173671 DOI: 10.1186/1471-2407-12-546] [Cited by in Crossref: 67] [Cited by in F6Publishing: 72] [Article Influence: 6.7] [Reference Citation Analysis]
33 Redova M, Poprach A, Besse A, Iliev R, Nekvindova J, Lakomy R, Radova L, Svoboda M, Dolezel J, Vyzula R. MiR-210 expression in tumor tissue and in vitro effects of its silencing in renal cell carcinoma. Tumour Biol. 2013;34:481-491. [PMID: 23150176 DOI: 10.1007/s13277-012-0573-2] [Cited by in Crossref: 56] [Cited by in F6Publishing: 50] [Article Influence: 5.6] [Reference Citation Analysis]
34 Duns G, van den Berg A, van Dijk MC, van Duivenbode I, Giezen C, Kluiver J, van Goor H, Hofstra RM, van den Berg E, Kok K. The entire miR-200 seed family is strongly deregulated in clear cell renal cell cancer compared to the proximal tubular epithelial cells of the kidney. Genes Chromosomes Cancer 2013;52:165-73. [PMID: 23074016 DOI: 10.1002/gcc.22016] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 2.2] [Reference Citation Analysis]
35 Sanders I, Holdenrieder S, Walgenbach-Brünagel G, von Ruecker A, Kristiansen G, Müller SC, Ellinger J. Evaluation of reference genes for the analysis of serum miRNA in patients with prostate cancer, bladder cancer and renal cell carcinoma. Int J Urol. 2012;19:1017-1025. [PMID: 22788411 DOI: 10.1111/j.1442-2042.2012.03082.x] [Cited by in Crossref: 67] [Cited by in F6Publishing: 71] [Article Influence: 6.7] [Reference Citation Analysis]
36 Yamasaki T, Seki N, Yamada Y, Yoshino H, Hidaka H, Chiyomaru T, Nohata N, Kinoshita T, Nakagawa M, Enokida H. Tumor suppressive microRNA138 contributes to cell migration and invasion through its targeting of vimentin in renal cell carcinoma. Int J Oncol. 2012;41:805-817. [PMID: 22766839 DOI: 10.3892/ijo.2012.1543] [Cited by in Crossref: 55] [Cited by in F6Publishing: 56] [Article Influence: 5.5] [Reference Citation Analysis]
37 Osanto S, Qin Y, Buermans HP, Berkers J, Lerut E, Goeman JJ, van Poppel H. Genome-wide microRNA expression analysis of clear cell renal cell carcinoma by next generation deep sequencing. PLoS One 2012;7:e38298. [PMID: 22745662 DOI: 10.1371/journal.pone.0038298] [Cited by in Crossref: 85] [Cited by in F6Publishing: 81] [Article Influence: 8.5] [Reference Citation Analysis]
38 Dey N, Das F, Ghosh-Choudhury N, Mandal CC, Parekh DJ, Block K, Kasinath BS, Abboud HE, Choudhury GG. microRNA-21 governs TORC1 activation in renal cancer cell proliferation and invasion. PLoS One 2012;7:e37366. [PMID: 22685542 DOI: 10.1371/journal.pone.0037366] [Cited by in Crossref: 46] [Cited by in F6Publishing: 43] [Article Influence: 4.6] [Reference Citation Analysis]
39 Zhai Q, Zhou L, Zhao C, Wan J, Yu Z, Guo X, Qin J, Chen J, Lu R. Identification of miR-508-3p and miR-509-3p that are associated with cell invasion and migration and involved in the apoptosis of renal cell carcinoma. Biochem Biophys Res Commun 2012;419:621-6. [PMID: 22369946 DOI: 10.1016/j.bbrc.2012.02.060] [Cited by in Crossref: 74] [Cited by in F6Publishing: 71] [Article Influence: 7.4] [Reference Citation Analysis]
40 Lichner Z, Mejia-Guerrero S, Ignacak M, Krizova A, Bao TT, Girgis AH, Youssef YM, Yousef GM. Pleiotropic action of renal cell carcinoma-dysregulated miRNAs on hypoxia-related signaling pathways. Am J Pathol 2012;180:1675-87. [PMID: 22326755 DOI: 10.1016/j.ajpath.2011.12.030] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 4.1] [Reference Citation Analysis]
41 Liu Y, Yin B, Zhang C, Zhou L, Fan J. Hsa-let-7a functions as a tumor suppressor in renal cell carcinoma cell lines by targeting c-myc. Biochemical and Biophysical Research Communications 2012;417:371-5. [DOI: 10.1016/j.bbrc.2011.11.119] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 4.1] [Reference Citation Analysis]
42 Valera VA, Walter BA, Linehan WM, Merino MJ. Regulatory Effects of microRNA-92 (miR-92) on VHL Gene Expression and the Hypoxic Activation of miR-210 in Clear Cell Renal Cell Carcinoma. J Cancer 2011;2:515-26. [PMID: 22043236 DOI: 10.7150/jca.2.515] [Cited by in Crossref: 51] [Cited by in F6Publishing: 54] [Article Influence: 4.6] [Reference Citation Analysis]
43 Wulfken LM, Moritz R, Ohlmann C, Holdenrieder S, Jung V, Becker F, Herrmann E, Walgenbach-Brünagel G, von Ruecker A, Müller SC, Ellinger J. MicroRNAs in renal cell carcinoma: diagnostic implications of serum miR-1233 levels. PLoS One 2011;6:e25787. [PMID: 21984948 DOI: 10.1371/journal.pone.0025787] [Cited by in Crossref: 165] [Cited by in F6Publishing: 156] [Article Influence: 15.0] [Reference Citation Analysis]
44 White NM, Bao TT, Grigull J, Youssef YM, Girgis A, Diamandis M, Fatoohi E, Metias M, Honey RJ, Stewart R, Pace KT, Bjarnason GA, Yousef GM. miRNA Profiling for Clear Cell Renal Cell Carcinoma: Biomarker Discovery and Identification of Potential Controls and Consequences of miRNA Dysregulation. Journal of Urology 2011;186:1077-83. [DOI: 10.1016/j.juro.2011.04.110] [Cited by in Crossref: 143] [Cited by in F6Publishing: 138] [Article Influence: 13.0] [Reference Citation Analysis]
45 Saini S, Yamamura S, Majid S, Shahryari V, Hirata H, Tanaka Y, Dahiya R. MicroRNA-708 induces apoptosis and suppresses tumorigenicity in renal cancer cells. Cancer Res 2011;71:6208-19. [PMID: 21852381 DOI: 10.1158/0008-5472.CAN-11-0073] [Cited by in Crossref: 98] [Cited by in F6Publishing: 54] [Article Influence: 8.9] [Reference Citation Analysis]
46 Oosterwijk E, Rathmell WK, Junker K, Brannon AR, Pouliot F, Finley DS, Mulders PF, Kirkali Z, Uemura H, Belldegrun A. Basic research in kidney cancer. Eur Urol 2011;60:622-33. [PMID: 21741760 DOI: 10.1016/j.eururo.2011.06.048] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 3.9] [Reference Citation Analysis]
47 Dall'Oglio MF, Coelho RF, Leite KR, Sousa-Canavez JM, Oliveira PS, Srougi M. Gene expression profile of renal cell carcinoma clear cell type. Int Braz J Urol 2010;36:410-8; discussion 418-9. [PMID: 20815947 DOI: 10.1590/s1677-55382010000400004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
48 Seliger B, Jasinski S, Dressler SP, Marincola FM, Recktenwald CV, Wang E, Lichtenfels R. Linkage of microRNA and proteome-based profiling data sets: a perspective for the priorization of candidate biomarkers in renal cell carcinoma? J Proteome Res 2011;10:191-9. [PMID: 21142213 DOI: 10.1021/pr1011137] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
49 Catto JW, Alcaraz A, Bjartell AS, De Vere White R, Evans CP, Fussel S, Hamdy FC, Kallioniemi O, Mengual L, Schlomm T, Visakorpi T. MicroRNA in prostate, bladder, and kidney cancer: a systematic review. Eur Urol. 2011;59:671-681. [PMID: 21296484 DOI: 10.1016/j.eururo.2011.01.044] [Cited by in Crossref: 317] [Cited by in F6Publishing: 306] [Article Influence: 28.8] [Reference Citation Analysis]
50 Li JY, Yong TY, Michael MZ, Gleadle JM. Review: The role of microRNAs in kidney disease. Nephrology (Carlton). 2010;15:599-608. [PMID: 20883280 DOI: 10.1111/j.1440-1797.2010.01363.x] [Cited by in Crossref: 93] [Cited by in F6Publishing: 88] [Article Influence: 8.5] [Reference Citation Analysis]
51 Bhatt K, Mi QS, Dong Z. microRNAs in kidneys: biogenesis, regulation, and pathophysiological roles. Am J Physiol Renal Physiol 2011;300:F602-10. [PMID: 21228106 DOI: 10.1152/ajprenal.00727.2010] [Cited by in Crossref: 123] [Cited by in F6Publishing: 127] [Article Influence: 11.2] [Reference Citation Analysis]
52 Redova M, Svoboda M, Slaby O. MicroRNAs and their target gene networks in renal cell carcinoma. Biochem Biophys Res Commun. 2011;405:153-156. [PMID: 21232526 DOI: 10.1016/j.bbrc.2011.01.019] [Cited by in Crossref: 49] [Cited by in F6Publishing: 45] [Article Influence: 4.5] [Reference Citation Analysis]
53 Zhou L, Chen J, Li Z, Li X, Hu X, Huang Y, Zhao X, Liang C, Wang Y, Sun L. Integrated profiling of microRNAs and mRNAs: microRNAs located on Xq27.3 associate with clear cell renal cell carcinoma. PLoS One. 2010;5:e15224. [PMID: 21253009 DOI: 10.1371/journal.pone.0015224] [Cited by in Crossref: 301] [Cited by in F6Publishing: 299] [Article Influence: 25.1] [Reference Citation Analysis]
54 Teferedegne B, Murata H, Quiñones M, Peden K, Lewis AM. Patterns of microRNA expression in non-human primate cells correlate with neoplastic development in vitro. PLoS One 2010;5:e14416. [PMID: 21203544 DOI: 10.1371/journal.pone.0014416] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
55 Ueno K, Hirata H, Shahryari V, Chen Y, Zaman MS, Singh K, Tabatabai ZL, Hinoda Y, Dahiya R. Tumour suppressor microRNA-584 directly targets oncogene Rock-1 and decreases invasion ability in human clear cell renal cell carcinoma. Br J Cancer 2011;104:308-15. [PMID: 21119662 DOI: 10.1038/sj.bjc.6606028] [Cited by in Crossref: 74] [Cited by in F6Publishing: 66] [Article Influence: 6.2] [Reference Citation Analysis]
56 Slaby O, Jancovicova J, Lakomy R, Svoboda M, Poprach A, Fabian P, Kren L, Michalek J, Vyzula R. Expression of miRNA-106b in conventional renal cell carcinoma is a potential marker for prediction of early metastasis after nephrectomy. J Exp Clin Cancer Res. 2010;29:90. [PMID: 20609231 DOI: 10.1186/1756-9966-29-90] [Cited by in Crossref: 82] [Cited by in F6Publishing: 76] [Article Influence: 6.8] [Reference Citation Analysis]
57 Liu H, Brannon AR, Reddy AR, Alexe G, Seiler MW, Arreola A, Oza JH, Yao M, Juan D, Liou LS, Ganesan S, Levine AJ, Rathmell WK, Bhanot GV. Identifying mRNA targets of microRNA dysregulated in cancer: with application to clear cell Renal Cell Carcinoma. BMC Syst Biol 2010;4:51. [PMID: 20420713 DOI: 10.1186/1752-0509-4-51] [Cited by in Crossref: 184] [Cited by in F6Publishing: 176] [Article Influence: 15.3] [Reference Citation Analysis]
58 Schaefer A, Stephan C, Busch J, Yousef GM, Jung K. Diagnostic, prognostic and therapeutic implications of microRNAs in urologic tumors. Nat Rev Urol 2010;7:286-97. [PMID: 20368743 DOI: 10.1038/nrurol.2010.45] [Cited by in Crossref: 79] [Cited by in F6Publishing: 82] [Article Influence: 6.6] [Reference Citation Analysis]